News
Pancreatic Cancer Vaccines – A New Hope in Oncology
Ductal adenocarcinoma of the pancreas remains one of the most lethal malignancies, with a global 5-year survival rate below 10% and a median recurrence-free survival of less than 14 months after resection. Despite progress in surgery and adjuvant therapies, the tumor’s aggressiveness and resistance to standard chemotherapy make it a diagnosis that continues to defy therapeutic advances. These challenges have led researchers to focus increasingly on immunotherapy—particularly the use of therapeutic vaccines.
Does It Matter Which Arm You Use for a Booster Shot?
The arm you choose for a booster vaccination might actually matter. A study published in the…
New Imaging Probe Lights Up Brain Tumors
A promising innovation in tumor visualization using fatty acid uptake has been introduced by a team…
What Are Physicians’ Nutrition Competencies Around the World?
Nutrition plays a fundamental role in the prevention and treatment of non-communicable diseases.…
Different Dietary Components Alter Gut Microbiota. What Does That Mean for Immunity?
The gut “microzoo” is highly diverse, influenced by many factors. Today, it’s well recognized that our...
“Clinical Bites” – Research Highlights 2025/28
Here are the first refreshing September updates from across medical fields, covering topics such as…
AI Could Transform Cancer Treatment by Precisely Identifying Tumor Cells
A new artificial intelligence tool called AAnet, developed and tested by researchers led by the…
Europe Reads DNA: Genomic Projects Shaping the Future
Breakthroughs that enable easy sequencing of large portions of the genome represent a major…
How Do Chronic and Acute Stress Affect the Gastrointestinal Tract?
The link between chronic stress and changes in the digestive tract is well supported by numerous…
Younger Generations Increasingly Affected by Appendix Cancer
Although appendiceal adenocarcinoma (AA) is a rare disease, its rising incidence among younger age…